Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
1.560
-0.050 (-3.11%)
At close: Oct 28, 2025, 4:00 PM EDT
1.550
-0.010 (-0.63%)
After-hours: Oct 28, 2025, 7:36 PM EDT
Skye Bioscience Employees
Skye Bioscience had 16 employees as of December 31, 2024. The number of employees increased by 5 or 45.45% compared to the previous year.
Employees
16
Change (1Y)
5
Growth (1Y)
45.45%
Revenue / Employee
n/a
Profits / Employee
-$2,648,310
Market Cap
48.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16 | 5 | 45.45% |
| Dec 31, 2023 | 11 | 0 | - |
| Dec 31, 2022 | 11 | 2 | 22.22% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | 6 | 2 | 50.00% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
SKYE News
- 16 hours ago - Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer - GlobeNewsWire
- 22 days ago - Skye Bioscience, Inc. - Special Call - Seeking Alpha
- 22 days ago - Nasdaq Jumps Over 150 Points; Skye Bioscience Shares Plunge - Benzinga
- 22 days ago - Skye Bioscience's Investigational Drug Disappoints As Monotherapy For Weight Loss - Benzinga
- 22 days ago - Skye Bioscience's obesity drug fails to meet main goal of mid-stage study - Reuters
- 22 days ago - Skye Bioscience Reports Topline CBeyond™ Phase 2a Data from Nimacimab Monotherapy and Combination Clinical Trial - GlobeNewsWire
- 27 days ago - Skye Bioscience: Promising Nimacimab Data Supports Buy Rating - Seeking Alpha
- 5 weeks ago - Could This New Drug Be The Safer Way To Fight Obesity? - Benzinga